We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600000:SSEShanghai Pudong Development Bank Co., Ltd. Class A Analysis

Data as of 2026-03-14 - not real-time

CN¥10.26

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Shanghai Pudong Development Bank trades at CNY 10.26, sitting just above its 20‑day SMA (9.93) but below the 50‑day (10.63) and 200‑day (12.22) averages, signaling a short‑term bounce within a broader bearish backdrop. The MACD histogram is positive and the MACD line sits above its signal, indicating bullish momentum, while the RSI of 55 suggests neither overbought nor oversold conditions. Volume is increasing, supporting the recent price lift, and the 30‑day volatility of 16.4% is moderate, yet the computed beta of ~0.02 points to very low market‑wide risk.
On the valuation side, the stock’s trailing PE of 7.33 is less than half the industry average of 16.35, and a price‑to‑book of 0.39 underscores deep discounting relative to its book value. A 4% dividend yield with a payout ratio under 30% appears sustainable, offering attractive income. However, revenue growth is modest at 2.6% and the sector faces heightened regulatory scrutiny in China, which tempers upside expectations. Overall, the combination of cheap multiples, solid dividend, and low beta supports a cautiously optimistic stance, especially for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with rising volume
  • Price approaching short‑term resistance at 10.41
  • Attractive 4% dividend yield

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Price remains below 50‑day and 200‑day SMAs indicating bearish medium‑term trend
  • Modest revenue growth and sector regulatory headwinds
  • Low systematic risk reflected by near‑zero beta

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount (PE ~7 vs industry ~16)
  • Sustainable high dividend yield
  • Low beta and strong cash position relative to debt

Key Metrics & Analysis

Financial Health

Revenue Growth256.50%
Profit Margin28.75%
P/E Ratio7.3
ROE6.31%
P/B Ratio0.4
Industry P/E16.4

Technical Analysis

TrendBearish
RSI55.4
SupportCN¥9.43
ResistanceCN¥10.41
MA 20CN¥9.93
MA 50CN¥10.63
MA 200CN¥12.22
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.00%

Risk Assessment

Beta0.02
Volatility16.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.